Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kohei, Kyo"'
Autor:
Testuro Ochi, Yuta Katayama, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Shinya Katsutani, Koji Iwato, Hideki Asaoku
Publikováno v:
Medical Mycology Case Reports, Vol 18, Iss , Pp 1-4 (2017)
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy. As zygomycosis could not be cured by liposomal amphotericin B and micafungin, left low
Externí odkaz:
https://doaj.org/article/04ecaaa23edd485081888b0ac563060d
Autor:
Takeshi Okatani, Mitsuhiro Itagaki, Kohei Kyo, Koji Iwato, Hideki Asaoku, Testuro Ochi, Ryota Imanaka, Yuta Katayama, Shinya Katsutani
Publikováno v:
Medical Mycology Case Reports
Medical Mycology Case Reports, Vol 18, Iss, Pp 1-4 (2017)
Medical Mycology Case Reports, Vol 18, Iss, Pp 1-4 (2017)
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy. As zygomycosis could not be cured by liposomal amphotericin B and micafungin, left low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::effe5379f9e44fec16e03051f9c32c3c
http://europepmc.org/articles/PMC5501889
http://europepmc.org/articles/PMC5501889
Autor:
Tetsuro, Ochi, Koji, Iwato, Yuta, Katayama, Kayo, Toishigawa, Takeshi, Okatani, Ryota, Imanaka, Kohei, Kyo, Mitsuhiro, Itagaki, Shinnya, Katsutani, Hideki, Asaoku, Taiichi, Kyo
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 57(11)
An 18-year-old male was admitted to our hospital for fever, and was diagnosed with acute megakaryoblastic leukemia (AML M7) based on the presence of CD42a and CD61 positive myeloblasts in peripheral blood (PB). Induction chemotherapy at our hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a5857a5aadaf88c66a643d15223a03e7
https://pubmed.ncbi.nlm.nih.gov/27941279
https://pubmed.ncbi.nlm.nih.gov/27941279
Autor:
Fumiaki Jinnouchi, Hideki Asaoku, Ryota Imanaka, Koji Iwato, Shinya Katsutani, Yu Kochi, Tatsuji Mino, Tasuya Terasaki, Yoshimasa Suetsugu, Mitsuhiro Itagaki, Takeshi Okatani, Kohei Kyo, Tsuyoshi Muta, Masaaki Noda, Yuta Katayama
Publikováno v:
Blood. 132:5321-5321
Background: Follicular lymphoma (FL) shows indolent clinical course and the optimal management strategy includes watchful waiting (WW). To define prognostic models for WW in clinical practice, we focused on serum soluble interleukin-2 receptor (sIL-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f68416b161710c2c85f830618924fd19
https://doi.org/10.1182/blood-2018-99-116016
https://doi.org/10.1182/blood-2018-99-116016
Autor:
Koji Iwato, Tsuyoshi Muta, Fumiaki Jinnouchi, Hideki Asaoku, Yuta Katayama, Shinya Katsutani, Takeshi Okatani, Yu Kochi, Kohei Kyo, Tatsuya Terasaki, Tatsuji Mino, Mitsuhiro Itagaki, Ryota Imanaka
Publikováno v:
Blood. 132:2095-2095
Background: Indications for allogeneic hematopoietic stem cell transplantation (allo-HCT) with reduced-intensity conditioning (RIC) have expanded widely for elderly patients and those with comorbidities. However, the optimal RIC regimen remains uncer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e1d4a5baa12a23b2a5cc93dfd426e58
https://doi.org/10.1182/blood-2018-99-113461
https://doi.org/10.1182/blood-2018-99-113461
Autor:
Taiichi Kyo, Tetsuro Ochi, Mitsuhiro Itagaki, Yuta Katayama, Kayo Toishigawa, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Koji Iwato, Hideki Asaoku
Publikováno v:
Blood. 126:1594-1594
Background: Imatinib (IMA), a first-generation tyrosine kinase inhibitor (TKI), has enabled safer, more successful treatment of chronic myeloid leukemia (CML). Moreover, second-generation TKIs such as nilotinib (NIL) and dasatinib (DAS) have enabled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cbedb92bb5888f6f0e44fefb82d4116
https://doi.org/10.1182/blood.v126.23.1594.1594
https://doi.org/10.1182/blood.v126.23.1594.1594
Autor:
Koji Iwato, Ryota Imanaka, Hisao Nagoshi, Kohei Kyo, Mitsuhiro Itagaki, Takeshi Okatani, Hideki Asaoku, Yuta Katayama, Taiichi Kyo, Tetsuro Ochi
Publikováno v:
Blood. 124:5272-5272
Introduction Chromosomal aberration is a powerful prognostic factor for acute myeloid leukemia (AML). On the other hand, age and high leukocyte counts at diagnosis are additional prognostic factors. In the case of high leukocyte counts, chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e47b9550c62b2150c2db974279e299
https://doi.org/10.1182/blood.v124.21.5272.5272
https://doi.org/10.1182/blood.v124.21.5272.5272